Characterization of atrial fibrillation and thromboembolic risk in patients of the Hospital León Cuervo Rubio
Keywords:
Atrial Fibrillation, Heart disease, Risk factor's, ThromboembolismAbstract
Introduction: among cardiac pathologies, atrial fibrillation is related to a high incidence of thromboembolic diseases.
Objective: to clinically and epidemiologically characterize atrial fibrillation and thromboembolic risk in patients attended at the León Cuervo Rubio Hospital in Pinar del Río between 2017 and 2019.
Methods: an observational, descriptive, cross-sectional, descriptive study was conducted on patients with atrial fibrillation attended at the León Cuervo Rubio Hospital in Pinar del Río from 2017 to 2019. The study universe consisted of 198 patients diagnosed with atrial arrhythmias in that hospital, the sample was constituted by 68 patients who met the inclusion and exclusion criteria.
Results: female sex predominated (58.8%). The most representative age group was 75 to 85 years old (45.5 %). Some type of heart disease associated with atrial fibrillation was present in 69.1% of patients. Persistent atrial fibrillation predominated (35.2%). Palpitations predominated as symptoms of atrial fibrillation (91.1%). Most patients with atrial fibrillation were in the moderate thromboembolic risk category (66.1%).
Conclusions: the predominant sex was female, the most affected age group was over 85 years, ischemic heart disease was the most prevalent history, persistent atrial fibrillation was the most frequent, palpitations were the main symptom, and according to the thromboembolic risk category, most patients were at moderate risk.
Downloads
References
1. Reyes Sanamé FA, Pérez Álvarez ML, Alfonso Figueredo E, Núñez Molina B, Jiménez Rodríguez K. Fibrilación auricular. Panorámica sobre un tema actualizado. CCM [Internet]. 2018 [citado 22 Mar 2022];22(4):695-718. Disponible en: http://www.revcocmed.sld.cu/index.php/cocmed/article/view/2962/1335
2. Soto Becerra R, Zafra Tanaka JH, Goicochea Lugo S, Alarcon Ruiz CA, Pacheco Barrios K, Taype Rondan A, et al. Guía de práctica clínica para el manejo de pacientes con fibrilación auricular en el Seguro Social del Perú (EsSalud). An Fac med [Internet]. 2019 [citado 22 Mar 2022];80(2):250-63. Disponible en: https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/16424/14162
3. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J [Internet]. 2012 [citado 22 Mar 2022];33(21):2719- 47. Disponible en: https://academic.oup.com/eurheartj/article/33/21/2719/493051
4. Borre ED, Goode A, Raitz G, Shah B, Lowenstern A, Chatterjee, et al. Predicting Thromboembolic and Bleeding Event Risk in Patients with Non-Valvular Atrial Fibrillation: A Systematic Review. Thromb Haemost [Internet]. 2018 [citado 22 Mar 2022];118(12):2171–87. Disponible en: https://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-0038-1675400
5. Forero Gómez JE, Moreno JM, Agudelo CA, Rodríguez Arias EA, Sánchez Moscoso PA. Fibrilación auricular: enfoque para el médico no cardiólogo. Iatreia [Internet]. 2017 [citado 22 Mar 2022];30(4):404-22. Disponible en: https://revistas.udea.edu.co/index.php/iatreia/article/view/323689/20785586
6. Acanfora D, Ciccone MM, Scicchitano P, Ricci G, Acanfora C, Uguccioni, M, et al. Efficacy and Safety of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and High Thromboembolic Risk. A Systematic Review. Front Pharmacol [Internet]. 2019 [citado 22 Mar 2022];10(9):1048-58. Disponible en: https://www.frontiersin.org/articles/10.3389/fphar.2019.01048/full
7. Pulido Medina C. Evaluación del riesgo de sangrado en pacientes con fibrilación auricular no valvular. Rev Colomb Cardiol [Internet]. 2017 [citado 22 Mar 2022];24(4):421-22. Disponible en: https://www.rccardiologia.com/previos/RCC%202017%20Vol.%2024/RCC_2017_24_4_JUL-AGO/RCC_2017_24_4_421-422.pdf
8. Dávila Hernández CA, Carranza Quispe FF. Características clínicas y epidemiológicas de la fibrilación auricular en pacientes del Hospital Regional de Ica. Rev Soc Peru Med Interna. [Internet]. 2018 [citado 22 Mar 2022];31(2):45-9. Disponible en: http://revistamedicinainterna.net/index.php/spmi/article/download/31/30/
9. Goire Guevara G, Cuza Díaz LA, Fournier Calzado G, González Marrero J, Montero Vega V. Factores de riesgo en complicaciones tromboembólicas cerebrales de pacientes con fibrilación auricular permanente no valvular. Rev inf cient [Internet]. 2019 [citado 22 Mar 2022];98(1):77-87. Disponible en: http://scielo.sld.cu/pdf/ric/v98n1/1028-9933-ric-98-01-77.pdf
10. Moreno Peña LE, Hernández Hervis IT, Moreno Peña R, García Peñate G, García García D. Conducta antitrombótica en pacientes con fibrilación auricular e ictus isquémico. Hospital Faustino Pérez. Año 2017. Rev Med Electrón [Internet]. 2018 [citado 22 Mar 2022];40(3):703-14. Disponible en: http://scielo.sld.cu/pdf/rme/v40n3/rme120318.pdf
11. Quintana Bullain A, Díaz León M, Mendieta Pedroso MD, López Pérez HG. Utilidad de escala de riesgo para Ictus y tratamiento anticoagulante en la fibrilación auricular. MediMay [Internet]. 2020 [citado 22 Mar 2022];27(4):490-9. Disponible en: http://revcmhabana.sld.cu/index.php/rcmh/article/view/1835/pdf_287
12. Mora Llabata V, Dubois Marqués D, Roldán Torres I, Mateu Navarro C, Sanz García JJ, Moreno Ballester Victoria, et al. Prevalencia de fibrilación auricular y características de la fibrilación auricular no valvular en la población general. Registro AFINVA. Rev. Colomb. Cardiol. [Internet]. 2017 [citado 22 Mar 2022];24(1):26-33. Disponible en: https://www.rccardiologia.com/previos/RCC%202017%20Vol.%2024/RCC_2017_24_1_ENE-FEB/RCC_2017_24_1_026-033.pdf
13. Arce M, Femenía F, Palazzolo J, Trucco E, Rodriguez C, Baranchuk A. Frecuencia de fibrilación auricular y tratamiento con anticoagulantes orales en pacientes con marcapasos definitivo. Invest clín [Internet]. 2011 [citado 22 Mar 2022];52(1):58-68. Disponible en: http://ve.scielo.org/scielo.php?script=sci_arttext&pid=S0535-51332011000100007&lng=es&nrm=iso&tlng=es
14. López Mases P, Martínez Sabater A, Haba Ejarque J, Ballestar Tarín ML, Casal Angulo C. Características de las personas afectadas de fibrilación auricular en una consulta de cardiología. Gerokomos [Internet]. 2016 [citado 22 Mar 2022];27(2):58-62. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1134928X2016000200005&lng=es
15. Noya Chaveco ME, Moya González NL. Roca Goderich. Temas de Medicina Interna: Vol 1. 4ª ed. La Habana: Editorial de las Ciencias Médicas, 2017.
Downloads
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: authors retain their copyright and grant the journal the right of first publication of their work, which is simultaneously subject to the Creative Commons Attribution-NonCommercial 4.0 International License that allows third parties to share the work as long as the author and first publication in this journal are indicated, for non-commercial use. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional telematic archive or publishing it in a monographic volume) as long as the initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work via the Internet (e.g., in institutional telematic archives, in their web page or in Pre-print servers) before and during the submission process, which can lead to interesting exchanges and increase citations of the published work. (See The Open Access Effect).
